Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 5
1947 3
1948 1
1949 3
1950 5
1951 7
1952 12
1953 8
1954 10
1955 1
1956 3
1957 7
1958 13
1959 15
1960 6
1961 16
1962 9
1963 28
1964 33
1965 33
1966 28
1967 34
1968 39
1969 39
1970 35
1971 48
1972 46
1973 32
1974 32
1975 35
1976 32
1977 41
1978 56
1979 39
1980 33
1981 45
1982 43
1983 49
1984 52
1985 49
1986 43
1987 46
1988 36
1989 66
1990 107
1991 121
1992 113
1993 123
1994 135
1995 159
1996 127
1997 151
1998 177
1999 174
2000 219
2001 210
2002 217
2003 270
2004 275
2005 288
2006 316
2007 337
2008 380
2009 364
2010 447
2011 458
2012 517
2013 491
2014 545
2015 481
2016 577
2017 553
2018 567
2019 613
2020 758
2021 739
2022 644
2023 625
2024 190

Text availability

Article attribute

Article type

Publication date

Search Results

12,366 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous histiocytoses in children.
Fraitag S, Emile JF. Fraitag S, et al. Histopathology. 2022 Jan;80(1):196-215. doi: 10.1111/his.14569. Histopathology. 2022. PMID: 34958507 Review.
Until recently, cutaneous histiocytoses were classified according to the immunophenotype of the pathological cells, with differentiation between Langerhans cell histiocytosis (LCH) [CD1a+, CD207 (langerin)+] and non-Langerhans cell histiocytosis
Until recently, cutaneous histiocytoses were classified according to the immunophenotype of the pathological cells, with differentiation bet …
Endotracheal Xanthoma Disseminatum.
McLaughlin J, Martin D, Safi J, Shepherd RW, Shojaee S. McLaughlin J, et al. Am J Respir Crit Care Med. 2022 Oct 1;206(7):901-902. doi: 10.1164/rccm.202202-0285IM. Am J Respir Crit Care Med. 2022. PMID: 35758930 No abstract available.
Blinding Xanthoma Disseminatum.
Abueleinen KG, Marie MA, Abdel-Halim MRE. Abueleinen KG, et al. Am J Ophthalmol. 2023 Jan;245:e3-e5. doi: 10.1016/j.ajo.2022.09.010. Epub 2022 Oct 8. Am J Ophthalmol. 2023. PMID: 36216161 No abstract available.
Xanthoma disseminatum.
Gong HZ, Zheng HY, Li J. Gong HZ, et al. Lancet. 2018 Jan 20;391(10117):251. doi: 10.1016/S0140-6736(17)31934-7. Epub 2017 Oct 12. Lancet. 2018. PMID: 29031846 No abstract available.
Xanthoma disseminatum.
Kuligowski M, Gorkiewicz-Petkow A, Jablonska S. Kuligowski M, et al. Int J Dermatol. 1992 Apr;31(4):281-3. doi: 10.1111/j.1365-4362.1992.tb03573.x. Int J Dermatol. 1992. PMID: 1634296 No abstract available.
Hemophagocytic syndrome.
Kumakura S. Kumakura S. Intern Med. 2005 Apr;44(4):278-80. doi: 10.2169/internalmedicine.44.278. Intern Med. 2005. PMID: 15897634 Free article. No abstract available.
Histiocyte disorders.
Henter JI, Tondini C, Pritchard J. Henter JI, et al. Crit Rev Oncol Hematol. 2004 May;50(2):157-74. doi: 10.1016/j.critrevonc.2004.01.002. Crit Rev Oncol Hematol. 2004. PMID: 15157664 Review. No abstract available.
Multicentric reticulohistiocytosis.
Luz FB, Gaspar TAP, Kalil-Gaspar N, Ramos-e-Silva M. Luz FB, et al. J Eur Acad Dermatol Venereol. 2001 Nov;15(6):524-31. doi: 10.1046/j.1468-3083.2001.00362.x. J Eur Acad Dermatol Venereol. 2001. PMID: 11843211 Review.
12,366 results
You have reached the last available page of results. Please see the User Guide for more information.